Haematopoietic stem and progenitor cells in rheumatoid arthritis

Rheumatology

Volumn 50, Issue 2, 2011, Pages 252-260

  Colmegna, Inés ^a   Weyand, Cornelia M ^b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ageing; CD34+ cells; Haematopoietic progenitor cells; Rheumatoid arthritis; Telomeres

Indexed keywords

DNA; REACTIVE OXYGEN METABOLITE;

CD34 SELECTION; CELL AGING; DISEASE FREE SURVIVAL; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENOMIC INSTABILITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TELOMERE;

AGING; ANTIGENS, CD34; ARTHRITIS, RHEUMATOID; HEMATOPOIETIC STEM CELLS; HUMANS; TELOMERE;

EID: 78751688524     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq298     Document Type: Review

References (79)

1. Kirkwood TB. Understanding ageing from an evolutionary perspective. J Intern Med 2008;263:117-27.
2. Calado RT, Young NS. Telomere diseases. N Engl J Med 2009;361:2353-65.
3. Tsirpanlis G. Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections. Am J Kidney Dis 2008;51:131-44.
4. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62:1576-82.
5. Crowson CS, Liang KP, Therneau TM, Kremers HM, Gabriel SE. Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum 2010;62:378-82.
6. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008;121:S9-14.
7. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000;97:9203-8.
8. Zhang X, Nakajima T, Goronzy JJ, Weyand CM. Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis. Arthritis Rheum 2005;52:3839-49.
9. Schonland SO, Lopez C, Widmann T et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003;100:13471-6.
10. Fujii H, Shao L, Colmegna I, Goronzy JJ, Weyand CM. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA 2009;106:4360-5.
11. Goronzy JJ, Weyand CM. Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 2009;11:249.
12. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998;41:2108-16.
13. Lee WW, Yang ZZ, Li G, Weyand CM, Goronzy JJ. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol 2007;179:2609-15.
14. Goronzy JJ, Henel G, Sawai H et al. Costimulatory pathways in rheumatoid synovitis and T-cell senescence. Ann N Y Acad Sci 2005;1062:182-94.
15. Shao L, Fujii H, Colmegna I, Oishi H, Goronzy JJ, Weyand CM. Deficiency of the DNA repair enzyme atm in rheumatoid arthritis. J Exp Med 2009;206:1435-49.
16. Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 2008;58: 990-1000.
17. Challen GA, Boles NC, Chambers SM, Goodell MA. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 2010;6:265-78.
18. Sonoda Y. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. J Autoimmun 2008;30:136-44.
19. Beerman I, Bhattacharya D, Zandi S et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 2010;107:5465-70.
20. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008;132:631-44.
21. Gan B, DePinho RA. Mtorc1 signaling governs hematopoietic stem cell quiescence. Cell Cycle 2009;8:1003-6.
22. Massberg S, Schaerli P, Knezevic-Maramica I et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007;131:994-1008.
23. Massberg S, von Andrian UH. Novel trafficking routes for hematopoietic stem and progenitor cells. Ann N Y Acad Sci 2009;1176:87-93.
24. Geiger H, Rudolph KL. Aging in the lympho-hematopoietic stem cell compartment. Trends Immunol 2009;30:360-5.
25. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 2007;5:e201.
26. Rossi DJ, Bryder D, Zahn JM et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005;102:9194-9.
27. Mayack SR, Shadrach JL, Kim FS, Wagers AJ. Systemic signals regulate ageing and rejuvenation of blood stem cell niches. Nature 2010;463:495-500.
28. Castro-Malaspina H, Harris RE, Gajewski J et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood 2002;99: 1943-51.
29. Kantarjian H, O'Brien S, Cortes J et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer 2006;106:1090-8.
30. Kollman C, Howe CW, Anasetti C et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001;98:2043-51.
31. Song Z, Ju Z, Rudolph KL. Cell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status. Exp Gerontol 2009;44:75-82.
32. Hajek PC, Baker LL, Goobar JE et al. Focal fat deposition in axial bone marrow: MR characteristics. Radiology 1987; 162:245-9.
33. Moresi R, Tesei S, Costarelli L et al. Age- and gender-related alterations of the number and clonogenic capacity of circulating CD34+ progenitor cells. Biogerontology 2005;6:185-92.
34. Tempescul A, Ianotto JC, Hardy E, Quivoron F, Petrov L, Berthou C. Peripheral blood stem cell collection in elderly patients. Ann Hematol 2010;89:317-21.
35. Ogawa T, Kitagawa M, Hirokawa K. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech Ageing Dev 2000;117:57-68.
36. Offner F, Kerre T, De Smedt M, Plum J. Bone marrow CD34 cells generate fewer T cells in vitro with increasing age and following chemotherapy. Br J Haematol 1999; 104:801-8.
37. Ben-Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 2004; 113:8-13.
38. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22.
39. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91: 9857-60.
40. Ergen AV, Goodell MA. Mechanisms of hematopoietic stem cell aging. Exp Gerontol 45:286-90.
41. Marciniak-Czochra A, Stiehl T, Wagner W. Modeling of replicative senescence in hematopoietic development. Aging 2009;1:723-32.
42. Sudo K, Ema H, Morita Y, Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 2000;192:1273-80.
43. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008;132: 681-96.
44. Franceschi C, Capri M, Monti D et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128:92-105.
45. Nijnik A, Woodbine L, Marchetti C et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007;447:686-90.
46. Wagner W, Bork S, Horn P et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009;4:e5846.
47. Park Y, Gerson SL. DNA repair defects in stem cell function and aging. Annu Rev Med 2005;56:495-508.
48. Niedernhofer LJ. DNA repair is crucial for maintaining hematopoietic stem cell function. DNA Repair 2008;7: 523-9.
49. Varela E, Blasco MA. 2009 Nobel Prize in physiology or medicine: telomeres and telomerase. Oncogene 2010;29: 1561-5.
50. Lou Z, Wei J, Riethman H et al. Telomere length regulates ISG15 expression in human cells. Aging 2009;1: 608-21.
51. Campisi J, Yaswen P. Aging and cancer cell biology, 2009. Aging Cell 2009;8:221-5.
52. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science 2006;311: 1257.
53. Choudhury AR, Ju Z, Djojosubroto MW et al. CDKN1A deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 2007;39:99-105.
54. Ju Z, Jiang H, Jaworski M et al. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med 2007;13: 742-7.
55. Tomas-Loba A, Flores I, Fernandez-Marcos PJ et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 2008;135:609-22.
56. Allsopp RC, Morin GB, DePinho R, Harley CB, Weissman IL. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 2003;102: 517-20.
57. Yamaguchi H, Calado RT, Ly H et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005;352:1413-24.
58. Widmann T, Kneer H, Konig J, Herrmann M, Pfreundschuh M. Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation. Exp Hematol 2008;36:104-10.
59. Allsopp RC, Weissman IL. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene 2002;21: 3270-3.
60. Nalapareddy K, Jiang H, Guachalla Gutierrez LM, Rudolph KL. Determining the influence of telomere dysfunction and DNA damage on stem and progenitor cell aging: what markers can we use? Exp Gerontol 2008; 43:998-1004.
61. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008;88:557-79.
62. Rossi DJ, Seita J, Czechowicz A, Bhattacharya D, Bryder D, Weissman IL. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 2007;6:2371-6.
63. Zimmermann S, Glaser S, Ketteler R, Waller CF, Klingmuller U, Martens UM. Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells 2004;22:741-9.
64. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 2001;193:917-24.
65. Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT. Telomere length changes after umbilical cord blood transplant. Transfusion 2006;46:1038-43.
66. Chakraborty S, Sun CL, Francisco L et al. Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol 2009;27:791-8.
67. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol 2002;2:699-706.
68. Cairney CJ, Sanguinetti G, Ranghini E et al. A systems biology approach to Down syndrome: identification of Notch/Wnt dysregulation in a model of stem cells aging. Biochim Biophys Acta 2009;1792:353-63.
69. Ito K, Hirao A, Arai F et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004;431:997-1002.
70. Miyamoto K, Araki KY, Naka K et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007;1:101-12.
71. Ito K, Hirao A, Arai F et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006;12:446-51.
72. Tothova Z, Kollipara R, Huntly BJ et al. Foxos are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007;128:325-39.
73. Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007; 110:3056-63.
74. Papadaki HA, Kritikos HD, Gemetzi C et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood 2002;99:1610-9.
75. Snowden JA, Nink V, Cooley M et al. Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritis. Br J Haematol 1998;103:601-9.
76. Porta C, Caporali R, Epis O et al. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33:721-8.
77. Ruger B, Giurea A, Wanivenhaus AH et al. Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 2004;50:2157-66.
78. Lowenthal RM, Francis H, Gill DS. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant. J Rheumatol 2006;33:812-3.
79. Kushida T, Ueda Y, Umeda M et al. Allogeneic intra-bone marrow transplantation prevents rheumatoid arthritis in skg/jcl mice. J Autoimmun 2009;32:216-22.